It is therefore difficult to generalize their results to other samples, or to analyze clinicopathological factors such as breast cancer phenotype, Ki-67 levels, or the use of human epidermal growth factor receptor-2 (HER2) targeted therapy [7,8]. Here, MKI67 is linked to breast cancer.